0001628280-22-015035.txt : 20220520 0001628280-22-015035.hdr.sgml : 20220520 20220520161057 ACCESSION NUMBER: 0001628280-22-015035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220518 FILED AS OF DATE: 20220520 DATE AS OF CHANGE: 20220520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MILNE GEORGE M JR CENTRAL INDEX KEY: 0001179552 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36421 FILM NUMBER: 22947697 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001600620 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 BUSINESS PHONE: 250-708-4272 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 4 1 wf-form4_165307739688602.xml FORM 4 X0306 4 2022-05-18 0 0001600620 Aurinia Pharmaceuticals Inc. AUPH 0001179552 MILNE GEORGE M JR #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8 BRITISH COLUMBIA, CANADA 1 0 0 0 Restricted Stock Unit 2022-05-18 4 A 0 8733 0 A Common Shares 8733.0 8733 D Stock Option (right to buy) 11.45 2022-05-18 4 A 0 14612 0 A 2032-05-18 Common Stock 14612.0 14612 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant. The option vests in twelve equal monthly installments commencing on June 18, 2022. /s/ George M. Milne, Jr., Ph.D. 2022-05-20